Fig 1: CR8 attenuates activation of the p53-linked pro-apoptotic pathways following etoposide-induced DNA damage at the mRNA level.Neurons were treated with 50 µm of etoposide ± 1 µm CR8. Neurons were collected 24 h after treatment. qPCR quantification of expression of a Noxa, p21, Puma, Apaf-1, and Mcl-1; b promotor region of Noxa and p21; c miR-711 and miR-23a in primary cortical neurons at different time points after treatment. Results of qPCR were normalized to a GAPDH expression; b input DNA; and c U6 snRNA. CR8 attenuates relative expression of PUMA, NOXA, and p21 following 50 µm etoposide treatment (a). No change in Apaf-1 relative to controls was observed until 24 h (a). Etoposide induced increases in occupancy of p53 in the promoter region of Noxa, and p21 was attenuated by etoposide + CR8 (b). n = 3/group for all groups. Etoposide and etoposide + CR8 increased expression of miR-711 and decreased miR-23a compared to control neurons (c). n = 6/group for all groups. Data represent mean ± SEM of one-way ANOVA and Tukey post hoc analysis, *p < 0.05 vs. control, &p < 0.05 vs. etoposide + CR8 at the same time point
Fig 2: HSF1 and HSEs present in the introns of Pmaip1 gene are essential for its activation after heat shock.a Heat shock-induced HSF1 binding in introns of Pmaip1 analyzed by ChIP-qPCR in wild-type (WT) HECa10 cells and the clone with hemideletion (1/2HSE) of the perfect HSE in the second intron. b RT-qPCR assays of Pmaip1 and Hspa1a genes transcript levels after heat shock (HS) in cells described in panel a. Fold changes in reference to untreated cells are shown. c PMAIP1 level in the same cells analyzed by western blot. CPT treatment served as positive control for PMAIP1 upregulation. ACTB is shown as a control for loading. Lower panel shows the representative results of densitometric analyses of western blots; *p < 0.05. d Relative luciferase activity in the human 1205Lu cells stably expressing constitutively active HSF1 (aHSF1) in relation to control cells with the empty vector (Neo). Cells were transiently transfected with: the pGL3-Promoter vector (a), its derivatives with the part of the second intron of the mouse Pmaip1 gene acting as an enhancer, containing either wild-type (a1) or mutated HSE (a2), and the vector with the HSPA7 promoter (b) used as a positive control. Sequences of wild-type HSE from the second intron of mouse Pmaip1 (nucleotides 93–112 downstream from the exon2/intron2 boundary) and mutated HSE (mutHSE) are shown above the graph. Hats indicate the most essential G and C nucleotides in the HSE sequence. Presented are mean values and ± SD from three independent experiments (with three-five technical repeats each); *p < 0.05. e HSF1 protein levels detected by western blot documenting the complete HSF1 knockout (-) obtained in RKO cells by CRISPR/Cas9 editing. ACTB is shown as control for loading. f RT-qPCR assays of PMAIP1 and HSPA1A transcript levels after heat shock treatment in HSF1(+) (mix of control clones) and HSF1(-) (one of six individual clones; the same result was obtained for all clones) RKO cells. **p < 0.001.
Fig 3: CR8 attenuates activation of the p53-linked pro-apoptotic pathways following etoposide-induced DNA damage.Neurons were treated with 50 µm of etoposide ± 1 µm CR8. Twenty-four hours later whole-cell lysates were fractioned on SDS-polyacrylamide gel and immunoblotted with antibodies against phospho-ATM, ?-H2A.X, p53, phospho-p53, Puma, Noxa, and p21. Protein levels were quantified by densitometry, normalized to ß-actin, and presented as fold change compared with control untreated levels. Cell death occurs in all neurons treated with 50 µm etoposide (phospho-ATM and ?-H2A.X) including an increase in phospho-p53. However, 1 µm CR8 attenuates the etoposide-induced increase in downstream targets of p53 (Puma, Noxa, and p21). n = 3/group for all groups. Data represent mean ± SEM of one-way ANOVA and Tukey post hoc analysis, *p < 0.05 vs. control, &p < 0.05 vs. etoposide + CR8 at the same time point
Fig 4: Heat shock-induced HSF1 binding in the introns of the Pmaip1 gene correlates with upregulation of its expression and enhanced apoptosis in mouse spermatogenic cells.a Chromatin binding of HSF1 assessed by ChIP-Seq in isolated spermatocytes. Organization of mouse and human genes is shown below peaks of ChIP-Seq tags: bars—exons (darker bars—coding regions), lines—introns; corresponding start and stop codons are linked by light-gray dashed or solid lines, respectively; the positions of HSE or HSE-like motifs are indicated by the closed and open arrows, respectively. Right panel shows the magnitude of HSF1 binding in intronic HSE of the Pmaip1 gene in comparison to Hsph1 promoter based on data from ChIP-Seq extracted from GSE56735. b HSF1 binding in Pmaip1 introns analyzed by ChIP-PCR in isolated spermatocytes. Binding to the Hsph1 promoter is shown as a positive control. C control, physiological temperature of testes (32 °C); 38° and 43°, heat shock at 38 or 43 °C, respectively; M marker; - +, negative and positive PCR controls. c Induction of Pmaip1 transcription assayed by RT-PCR and RT-qPCR in isolated spermatocytes after heat shock in vitro at 43 °C and d in testes of mice after heat shock in vivo. 18S rRNA and Hspa1 were used as transcript level controls for loading and the heat shock response, respectively; C control, HS heat shock. e Accumulation of PMAIP1 protein after heat shock in vivo in mouse testes demonstrated by western blot. ACTB and HSPA1 were used as controls for loading and the heat shock response, respectively. f Induction of Pmaip1 transcription assayed by RT-PCR and RT-qPCR in testes of transgenic mice expressing constitutively active mutated HSF1 (aHSF1) during postnatal development; wt wild type, tg transgenic. Asterisks on the graphs indicate statistical significance of differences: *p < 0.05, **p < 0.001. g Accumulation of PMAIP1 in transgenic mouse testes demonstrated by western blot. ACTB was used as a control for loading. h Detection of PMAIP1 or HSF1 by immunofluorescence (green) and apoptotic DNA breaks (by TUNEL assay, red; DNA stained with DAPI, blue) in seminiferous tubules (stages IX–X) of untreated mice and after 6 h of recovery from heat shock in vivo (PMAIP1; upper panels) or the aHSF1 transgenic mouse (HSF1; bottom panel). Scale bar—50 µm.
Fig 5: PMAIP1 deficiency reduces heat-induced death and delays caspase-3 and caspase-7 activation.a Apoptosis and b necrosis of PMAIP1(+) and PMAIP1(-) HECa10 cells monitored between 2 and 24 h after heat shock or during bortezomib (Bort) or camptothecin (CPT) treatments. Shown are mean values ± SD from one (representative) of three independent experiments; the statistically significant difference between treated and untreated samples or PMAIP1(+) and PMAIP1(-) samples is marked with an asterisk (*p < 0.05, **p < 0.001). c PMAIP1(+) and PMAIP1(-) cells were heat-shocked for 1 h at 43 °C and protein extracts were analyzed by western blot up to 6 h of recovery. ACTB was used as a loading control. C untreated cells, CPT camptothecin treatment of wild-type HECa10 cells for 6 h (positive control for PMAIP1 induction); unspecific protein band recognized by anti-PMAIP1 Ab is marked with an asterisk. The graphs show the results of densitometric analyses from three independent experiments; *p < 0.05, **p < 0.001.
Supplier Page from MilliporeSigma for Anti-NOXA antibody produced in rabbit